An average clinical trial can cost $60-80 million. Adaptive design allows a sponsor to modify multiple parts of a trial without incurring additional costs. Using this innovative method will present the opportunity to stipulate collected data at various intervals in order to modify one or more detailed aspects of the study based on analysis of the data. It is proven that this approach will allow a trial to more efficiently demonstrate the effects of a drug. Our
Adaptive Clinical Trials Symposium brings together senior-level executives from pharmaceutical and biotechnology companies to examine the best practices when taking advantage of adaptive design through case studies, thought-provoking presentations, and interactive panel discussions.
When implementing an adaptive clinical trial design, you have the opportunity to use unique tactics without damaging the integrity of the study. This will allow a more proficient use of capital and resources through shorter time frames, allowing you to accelerate the clinical development process.
Join us to ensure you have all your questions answered. Gain key insights behind developing, using, and implementing an adaptive design in order to proactively boost clinical research and effectively lower costs. You will leave the
Adaptive Clinical Trials Symposium with a better comprehension analyzing statistics, data, and operations through an adaptive design for more efficient clinical trials.
Top Five Reasons to Attend
- Discover best practices for planning and managing an adaptive trial
- Learn from true industry experiences, how to get drugs to market faster at less cost
- Analysis of FDA guidance and tips to navigate through the gray areas associated with an adaptive design
- Uncover best practices for creating a program development strategy to include adaptive strategy
- Understand the role of interim analysis in adaptive design
Who Should Attend
This conference is designed for
representatives from pharmaceutical, biotechnology, clinical research
organizations, and clinical sites with responsibilities in the following
areas:
- Biostatistics
- Clinical Trial Design
- Clinical/Medical Research
- Clinical Operations
- Clinical Supplies
- Contract Research Organizations
- Data Management
- Medical Affairs
- Patient Recruitment
- Project Management
- Regulatory Affairs
- Drug Development
- Clinical Development
- Clinical Studies
- Clinical Scientists
This event is also of interest to:
- Clinical Research Organizations
- Clinical / Quality Risk Consultants
- Medical Informatics
- Business Development
- Patient Engagement and Retention Services
- Clinical Technology and Data Management Solution Providers
- Functional Service Providers
Speakers
- Jim Bolognese, Senior Director Strategic Consulting, CYTEL INC
- Divya Chadha Manek, Head of Business Development, NATIONAL INSTITUTE FOR HEALTH RESEARCH (NIHR), CLINICAL RESEARCH NETWORK (CRN)
- Mark Chang, Ph.D., Senior Vice President, Strategic Statistical Consulting, VERISTAT
- Vladimir Dragalin, Vice President and Scientific Fellow, Head of ACT CoE, JANSSEN
- Chitra Edwin, RAC Senior Vice President of Regulatory Affairs and Compliance, SPOTLIGHT INNOVATION
- Balazs Flink, Head of Clinical Trial Analytics, Business Insights and Analytics, BRISTOL-MYERS SQUIBB
- Lance Hill, CEO, WITHIN3
- Mingxiu Hu, Senior Vice President, Head of Data Science and R&D Systems, NEKTAR THERAPEUTICS
- Feng Liu, Manager Statistics, GLAXOSMITHKLINE
- Inna Perevozskaya, Senior Director and U.S. Team Lead, Statistical Innovation Group, GLAXOSMITHKLINE
- Elizabeth Presson, Patient Engagement and Digital Strategy Lead, OTICON MEDICAL, LLC
- Ramses Sadek, Ph.D., Professor of Biostatistics, Department of Population Health Sciences, DEPARTMENT OF POPULATION HEALTH SCIENCES, Director of Biostatistics Core, Georgia Cancer Center, AUGUSTA, UNIVERSITY
- Alex Sverdlov, Director, Statistical Sciences, NOVARTIS
- Chad Swanson, Ph.D., Director, Clinical Neuroscience, EISAI
- Yuehui Wu, Director Statistics, GLAXOSMITHKLINE
- Peter Zhang, Ph.D., Head of Biostatistics Department, OTSUKA
Please fill in your name and email to receive the conference agenda of this event.
Symposium Day One - Thursday, March 22
Symposium Day Two - Friday, March 23
The agenda is available as PDF under downloads at the right side of the page.
Venue
The venue is not yet available for this event.
Follow this event to be informed when the venue is available and stay informed on other changes.
Venue
Wyndham Philadelphia Historic District400 Arch Street
Philadelphia, PA 19106
Simply the best of both worlds. Just one block off Market Street and within walking distance of popular landmarks, including Independence National Park, Liberty Bell Center, Independence Hall, and Betsy Ross House. We’re also minutes away from the Philadelphia Convention Center, Art Museum, the Barnes Foundation, Franklin Institute, Rittenhouse Square, Penn’s Landing, and the Central Business District.
To make reservations, guests can call 1-877-999-3223 and request the group rate for ExL’s March Meetings. To make reservations online
Click HereThe group rate is available until February 28, 2018. Please book your room early, as rooms available at this rate are limited.
